Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship, 2021
    Children's Hospital of Philadelphia
  • Residency, Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology, 2020
    Nationwide Children's Hospital-GME
  • Residency, Pediatrics, 2017
    Nationwide Children's Hospital-GME
  • MD, 2015
    Johns Hopkins University School of Medicine
  • BA, 2011
    Johns Hopkins University

Board Certifications

  • American Board of Psychiatry & Neurology-Child Neurology

National Provider ID: 1629317664


Alexandra Kornbluh, M.D., completed her medical training at the Johns Hopkins School of Medicine and her pediatric and child neurology residency training through Nationwide Children’s Hospital in Columbus, Ohio. She then pursued additional subspecialty fellowship training in pediatric multiple sclerosis and related demyelinating diseases. Through this fellowship, she gained expertise in caring for both children and adults across the age-span of neuroinflammatory diseases at the Children’s Hospital of Philadelphia and the University of Pennsylvania.

Dr. Kornbluh sees patients from the greater Washington, D.C., area as well as second opinion consultations for pediatric demyelinating disease and related disorders within the multidisciplinary neuroimmunology program. She also evaluates patients with headaches and provides general neurology care for patients.

Dr. Kornbluh serves as the director of investigational therapeutics through the pediatric neuroimmunology program and is the principal investigator for clinical research studies in pediatric demyelinating conditions. Her research interests include pediatric multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disorders and other related demyelinating conditions. 

  • Acute disseminated encephalomyelitis (ADEM)
  • Acute Flaccid Myelitis
  • Autoimmune encephalitis
  • Headaches
  • Multiple Sclerosis
  • Myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD)
  • Neuromyelitis optica (NMO)
  • Optic neuritis
  • Transverse myelitis

Research & Publications

Kornbluh AB, Liu GT, Hopkins SE. Delayed Visual Improvement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Pediatr Neurol. 2022 Jan;126:43-45. doi: 10.1016/j.pediatrneurol.2021.10.006. Epub 2021 Oct 13. PMID: 34736062.

Kornbluh AB, Bradstreet LE, Hutchinson ML, Wilson CS. Serial neuropsychological testing in MOG antibody-associated disease to improve understanding of outcomes. Mult Scler Relat Disord. 2020 Sep;44:102316. doi: 10.1016/j.msard.2020.102316. Epub 2020 Jun 18. PMID: 32585614.

Kornbluh AB, Thompson K, Mcmahen G, Rogers DL, Jordan CO, Aylward SC, Lehwald LM. Sleep disturbance in pediatric intracranial hypertension. J Clin Sleep Med. 2020 Jul 15;16(7):1099-1105. doi: 10.5664/jcsm.8436. PMID: 32209220; PMCID: PMC7954056.

Kornbluh AB, Chung MG. Teaching NeuroImages: Transient cytotoxic edema in a child with a novel ATP1A2 mutation. Neurology. 2020 Sep 8;95(10):e1441-e1442. doi: 10.1212/WNL.0000000000010103. Epub 2020 Jul 8. PMID: 32641521.

Kornbluh A, Twanow JD. Teaching NeuroImages: Adolescent Wallenberg syndrome with overlooked signs: Ipsipulsion and ipsilateral facial palsy. Neurology. 2018 Nov 13;91(20):e1949-e1950. doi: 10.1212/WNL.0000000000006513. PMID: 30420466.

Tanner JA, Rao KT, Salas RE, Strowd RE, Nguyen AM, Kornbluh A, Mead-Brewer E, Gamaldo CE. Incorporating students into clinic may be associated with both improved clinical productivity and educational value. Neurol Clin Pract. 2017 Dec;7(6):474-482. doi: 10.1212/CPJ.0000000000000394. PMID: 29431166; PMCID: PMC5800714.